Childhood cancer survivors have higher risk of deadly heart disease in pregnancy

May 27, 2018, European Society of Cardiology

Girls who survive cancer have a higher risk of developing a deadly heart disease when pregnant later in life, according to a study presented today at Heart Failure 2018 and the World Congress on Acute Heart Failure, a European Society of Cardiology congress.

Researchers say young survivors should be warned of this pregnancy-associated called peripartum cardiomyopathy so that they can be closely monitored. Separately, the researchers found that women with existing peripartum cardiomyopathy are at increased risk of developing cancer.

"Our finding that cancer and peripartum cardiomyopathy share some biological markers in the blood suggests that there is a physiological connection between these diseases," said Professor Denise Hilfiker-Kleiner, author of the study and Dean of Research in Molecular Cardiology, Hannover Medical School, Germany.

Peripartum cardiomyopathy is a life-threatening type of failure where the heart becomes enlarged and weak in late pregnancy or after childbirth. It occurs in about one in 1,000 pregnant women worldwide. "Without treatment, up to 30% of women die and less than half of patients fully recover," said Professor Johann Bauersachs, Director of the Department of Cardiology and Angiology, Hannover Medical School.

"It has been suspected, without having real data, that cardiotoxic anticancer treatment injures the heart and years later a second stress on the heart like pregnancy induces cardiomyopathy," said Professor Hilfiker-Kleiner. "Our study provides evidence for links between the two diseases."

The two-part study was conducted using German registry data. In part one, Stella Schlothauer, a young medical student in Professor Hilfiker-Kleiner's lab, compared the ten-year prevalence of cancer, which occurred before or after peripartum cardiomyopathy in 207 women to the ten-year cancer prevalence in the general population of women aged 0-49 years in Germany.

Thirteen of the 207 women with peripartum cardiomyopathy had cancer during the ten-year period—a prevalence of 6.3%. One woman had two cancers. Of the 14 cancer diagnoses, nine occurred before peripartum cardiomyopathy and five occurred after peripartum cardiomyopathy. The ten-year cancer prevalence in the general population of women in Germany aged 0-49 years was 0.59%.

Professor Hilfiker-Kleiner said: "Women with peripartum cardiomyopathy had ten times more cancer, either before or after their heart failure, than the of women. About two-thirds of cancers occurred in children or young adults who then developed peripartum cardiomyopathy, while one-third were diagnosed two to three years after peripartum cardiomyopathy. We think there may be genetic or epigenetic factors which make women more prone to both diseases. This is on top of the long-term cardiotoxic effects of anticancer therapies."

In part two, the researchers analysed the blood of 47 women with peripartum cardiomyopathy and 29 healthy women of the same age and time since pregnancy to look for peptides and proteins associated with cancer. Levels of several of these cancer markers were higher in the peripartum cardiomyopathy group—for example human epidermal growth factor receptor 2 (HER2), a protein which is elevated in around one in five breast cancers. Compared to healthy women, cancer markers were elevated in women with peripartum regardless of whether or not they had previous or subsequent cancer during the study.

"Cancer survivors should be warned that they are at increased risk of pregnancy-associated heart failure," said Professor Hilfiker-Kleiner. "These are high-risk pregnancies and women need close monitoring of their hearts for any sign of heart failure. We need more data so that we can tell pregnant with a history of cancer how high their risk of developing a second deadly disease is."

"Women who develop are at higher risk of subsequent cancer and should make sure they attend routine cancer screening," she said.

Explore further: Researchers identify cause of heart failure in pregnant women

More information: The abstract 'High prevalence of cancer in patients with peripartum cardiomyopathy: is there a pathophysiological connection between these two entities?' will be presented during the session Young Investigator Award: Clinical which takes place on 27 May.

Related Stories

Researchers identify cause of heart failure in pregnant women

January 6, 2016
Each year approximately 1 in 1,000 pregnant women will experience peripartum cardiomyopathy, an uncommon form of often severe heart failure that occurs in the final month of pregnancy or up to five months following delivery. ...

A potential biomarker for pregnancy-associated heart disease?

April 24, 2013
Peripartum cardiomyopathy (PPCM) is a deterioration in cardiac function that occurs in pregnant women during the last month or in the months following their pregnancy. This disorder can occur in women with no prior history ...

Pregnancy-related heart failure strikes black women twice as often as those of other races

October 11, 2017
African American women were found to be twice as likely to be diagnosed with peripartum cardiomyopathy as compared to women of Caucasian, Hispanic/Latina, Asian, and other ethnic backgrounds, according to a new study—the ...

Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth

May 17, 2014
Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing ...

Peripartum cardiomyopathy occurs globally and is not a disease of the poor

March 8, 2017
Peripartum cardiomyopathy (PPCM) occurs globally and is not a disease of the poor, according to research published today in the European Journal of Heart Failure. Cases were reported from many countries for the first time.

Recommended for you

'Smart stent' detects narrowing of arteries

June 19, 2018
For every three individuals who have had a stent implanted to keep clogged arteries open and prevent a heart attack, at least one will experience restenosis—the renewed narrowing of the artery due to plaque buildup or scarring—which ...

Marriage may protect against heart disease / stroke and associated risk of death

June 18, 2018
Marriage may protect against the development of heart disease/stroke as well as influencing who is more likely to die of it, suggests a pooled analysis of the available data, published online in the journal Heart.

Deaths from cardiac arrest are misclassified, overestimated

June 18, 2018
Forty percent of deaths attributed to cardiac arrest are not sudden or unexpected, and nearly half of the remainder are not arrhythmic—the only situation in which CPR and defibrillators are effective—according to an analysis ...

Tick-borne meat sensitivity linked to heart disease

June 15, 2018
University of Virginia School of Medicine researchers have linked sensitivity to an allergen in red meat—a sensitivity spread by tick bites—with a buildup of fatty plaque in the arteries of the heart. This buildup may ...

Tobacco aside, e-cigarette flavorings may harm blood vessels

June 14, 2018
Flavor additives used in electronic cigarettes and related tobacco products could impair blood vessel function and may be an early indicator of heart damage, according to new laboratory research in Arteriosclerosis, Thrombosis ...

The molecules that energize babies' hearts

June 14, 2018
A metabolic process that provides heart muscle with energy fails to mature in newborns with thickened heart walls, according to a Japan–Canada research team.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.